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Increased Carotid Artery Intima-Media Thickness in
Subjects With Primary Hypoalphalipoproteinemia
Damiano Baldassarre, Mauro Amato, Linda Pustina, Elena Tremoli, Cesare R. Sirtori,
Laura Calabresi, Guido Franceschini
Abstract—The plasma concentration of high-density lipoprotein cholesterol (HDL-C) is inversely correlated with the
incidence of atherosclerotic vascular events. In the present study, we evaluated pre-intrusive atherosclerosis in subjects
with plasma HDL-C at the extremities of normal distribution. Fifty-five subjects with primary hypoalphalipoproteinemia
(HypoALP) or hyperalphalipoproteinemia (HyperALP) were compared with fifty-five control subjects with average
HDL-C levels, matched for sex, age, and plasma cholesterol. The average and maximal intima-media thicknesses
(Avg-IMT and Max-IMT) of 48 carotid segments for each subject were approximately 40% greater in HypoALP than
in control subjects (0.940.06 versus 0.690.04 mm, P0.004, and 1.860.16 versus 1.350.10 mm, P0.025,
respectively). The IMT values in HyperALP subjects (Avg-IMT, 0.710.04 and Max-IMT, 1.380.14 mm) were the
same as in controls. In a large cohort of hyperlipidemic subjects (n559), significantly greater Avg-IMT and Max-IMT
were found in subjects belonging to the first HDL-C quintile (42 mg/dL) than in all the others. The measurement of
carotid IMT in cases with HypoALP and HyperALP, and in a large series of hyperlipidemic patients, thus indicates that
a low HDL-C is associated with significant pre-intrusive atherosclerosis, whereas a HDL-C level above average values
does not lead to a further reduction of arterial wall thickening. (Arterioscler Thromb Vasc Biol. 2002;22:317-322.)
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Anumber of epidemiological studies have consistentlydemonstrated that a low plasma concentration of high-
density lipoprotein cholesterol (HDL-C) is an independent
risk factor for atherosclerotic vascular disease.1 Clinical
sequelae are generally preceded by silent changes in the
arterial wall, characterized by enhanced lipid deposition and
infiltration of blood cells into the subendothelial space.2 HDL
are believed to retard the formation of atherosclerotic lesions
in the arterial wall by removing excess cholesterol from cells3
and by preventing cell adhesion and transmigration.4 These
mechanisms may imply an increased thickening of the arterial
wall in individuals with low plasma HDL levels.5
High-resolution B-mode ultrasonography is a noninvasive
technique that allows pre-intrusive atherosclerotic changes in the
walls of the carotid and femoral arteries to be seen and provides
reliable and reproducible measurements of the thickness of the
arterial intima-media complex, the intima-media thickness
(IMT).6 Cross-sectional and population studies indicate an asso-
ciation between carotid IMT, cardiovascular risk factors,7,8 and
the prevalence of cardiovascular disease.9 More importantly, in
prospective studies,10,11 carotid IMT was able to predict clinical
coronary artery disease (CAD).
Hypoalphalipoproteinemia (HypoALP) defines a group of
dyslipidemias characterized by an HDL-C level below the 10th
percentile for the age- and sex-matched general population.12
HypoALP can be a marker of disorders in triglyceride and
glucose metabolism, can be caused by environmental factors, or
can directly result from mutations in a number of different genes,
like those coding for the ABCA1 transporter, the apolipoproteins
A-I and A-II, the lecithin:cholesterol acyltransferase (LCAT), or
lipoprotein lipase (LPL) enzymes.3 It is noteworthy that not all
of these conditions are associated with an increased risk of
premature CAD.13 Hyperalphalipoproteinemia (HyperALP) is
instead characterized by plasma HDL-C levels above the 90th
percentile for the age- and sex-matched general population.14
HyperALP can be acquired by exposure to certain environmen-
tal factors, but it is generally inherited as an autosomal dominant
trait,14 caused by mutations in either the cholesteryl ester transfer
protein (CETP) or hepatic lipase genes.3 This condition was
early associated with low CAD risk and longevity,15 but this
association has been recently questioned.16 The main purpose in
the present study was to assess the extent of pre-intrusive
atherosclerosis in individuals selected because of a primary
HypoALP or HyperALP.
Methods
Subjects
Fifty-five consecutive subjects with primary HypoALP (defined by a
plasma HDL-C level below the 10th percentile for the general
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population17) attending the E. Grossi Paoletti Lipid Clinic (Milan,
Italy) were recruited for the study. Individuals were excluded if they
fulfilled one of the following criteria: obesity (body mass index
[BMI] 30), diabetes mellitus, liver disease, kidney disease, thyroid
dysfunction, or history of alcohol abuse and/or heavy smoking. Age-
and sex-matched subjects with HyperALP (defined by a plasma
HDL-C above the 90th percentile for the general population) were
selected from the Lipid Clinic database, which includes 251 Hyper-
ALP subjects. Of these, 53 subjects were excluded because of
exclusion criteria. Among the remaining 198 subjects, the 55
subjects who matched for sex and the closest age (in years) to an
HypoALP subject were recruited for the study. A third group of
subjects (controls), matched for age, sex, and total and LDL
cholesterol, with a plasma HDL-C level between the 45th and the
55th percentiles for the general population, was randomly selected
from the Lipid Clinic database. No subject was taking medications
known to affect plasma lipid/lipoprotein levels.
A cohort of 559 consecutive hyperlipidemic subjects attending the
Laboratory for Non-Invasive Diagnosis of the Lipid Clinic also
participated in the study. Hyperlipidemia was defined by a low-
density lipoprotein cholesterol (LDL-C)130 mg/dL and/or trigly-
cerides 200 mg/dL.
After an overnight fast, blood was collected into tubes containing
Na2-EDTA (1 mg/mL), and plasma was prepared by low-speed
centrifugation. The measurement of plasma lipids was performed by
standard enzymatic techniques; HDL-C was determined after pre-
cipitation of apoB-containing lipoproteins,18 and LDL-C was calcu-
lated by using the Friedewald’s formula.19 Plasma Lp(a) levels were
measured by using ELISA.20
Ultrasonography
Ultrasound scanning and reading of carotid arteries were performed
by a single expert sonographer, using an 8-MHz transducer with an
axial and lateral resolution of 0.385 and 0.500 mm, respec-
tively.6,21 The sonographer was blinded to the subject’s identity. A
standard protocol, scanning the near and far walls of the right and left
common, internal and external carotid arteries, and bifurcations in
three different projections (anterior, lateral, and posterior), was
performed.21 Eight segments of the right and left carotid arteries in
each projection were examined, and the 48 IMT measurements were
averaged to calculate the average IMT (Avg-IMT) for each subject.
Less than 4% of all IMT measurements was missed because of
anatomical reasons; the missing value was replaced in the calculation
of Avg-IMT with the average of the remaining measurements for that
segment. The highest IMT value among the 48 segments was defined
as the maximum IMT (Max-IMT). As age has been shown to be the
strongest predictor of IMT,7,22 age-adjusted IMT values were used in
some analyses.
Statistical Analysis
The number of subjects needed to detect a difference in Avg-IMT
between the three groups of 0.20 mm with an SD of 0.30 mm, a
power of 80%, and 0.05 is 45 per group. Therefore, the study is
adequately powered to disprove multiple null hypotheses.
Results are reported as meanSEM, if not otherwise stated.
Logarithmic transformation was performed on individual values of
skewed variables. Group differences in continuous and categorical
variables were determined by using ANCOVA and a 2 test of
significance, respectively. Pearson correlation coefficients were
computed to assess the association between parameters. Multiple
stepwise regression analysis was performed with Avg-IMT or
Max-IMT as the dependent variable, and by entering the independent
variable with the highest partial correlation coefficient at each step,
until no variable remained with an F value of 4 or more. Group
differences or correlations with P0.05 were considered statistically
significant.
Results
The characteristics of the recruited subjects are shown in
Table 1. A trend toward lower BMI and fasting glucose
concentrations with increasing average HDL-C levels was
found, possibly indicative of the presence of some insulin-
resistant subjects in the HypoALP group; none of them,
however, was diabetic. Plasma triglycerides were signifi-
cantly higher in HypoALP than in HyperALP and control
subjects. There was no difference in plasma Lp(a), blood
pressure, or prevalence of smokers in the three examined
groups (Table 1).
Mean carotid IMT values in the three groups are shown in
Table 2. The intimal thickening of common carotid, bifurca-
tion, and internal carotid was significantly greater in the
HypoALP than in subjects with average plasma HDL-C
levels. The carotid Avg-IMT and Max-IMT were approxi-
mately 40% greater in the HypoALP group than in control
subjects. In contrast, the average thickness of the three carotid
segments, as well as the Avg-IMT and Max-IMT values,
were remarkably similar in HyperALP and control subjects
(Table 2). The IMT differences between HypoALP and the
other two groups remained significant after data adjustment
for BMI, triglycerides, and glucose (not shown). No signifi-
cant differences were found in Avg-IMT and Max-IMT
between the 34 hypertriglyceridemic (triglycerides200 mg/
dL) and the 21 normotriglyceridemic HypoALP subjects
(Avg-IMT, 0.910.31 versus 0.980.10 mm, respectively,
P0.56; Max-IMT, 1.790.15 versus 2.170.28 mm,
P0.20).
TABLE 1. Characteristics of Subjects With HypoALP and
HyperALP and of Controls
HypoALP Controls HyperALP
No. 55 55 55
Sex, F/M 20/35 20/35 20/35
Age, y 52.81.6 52.91.5 52.91.6
BMI, kg/m2 25.40.5 24.30.4 23.30.4†
Total cholesterol, mg/dL 267.88.6 263.17.3 276.88.4
LDL-cholesterol, mg/dL 178.28.40 185.77.5 183.78.4
HDL-cholesterol, mg/dL 30.90.8 49.90.6‡ 70.11.2‡
Triglycerides, mg/dL 229 (57–4630) 127 (60–434)† 99 (38–250)†
Lp(a), mg/dL 18 (1–135) 11 (1–101) 25 (1–193)
Glucose, mg/dL 100.82.5 95.32.6 92.91.4*
Systolic BP, mm Hg 135.42.4 130.22.3 133.52.1
Diastolic BP, mm Hg 84.31.4 83.01.4 83.51.5
Hypertension 21 (38.2%) 18 (32.7%) 14 (25.5%)
Smokers 39 (70.1%) 29 (52.7%) 29 (52.7%)
Data are expressed as meanSEM, except for triglycerides and Lp(a)
[median (range)] and hypertension and smokers [n (%)]. BP indicates blood
pressure.
*P0.05 vs HypoALP; †P0.01 vs HypoALP.
‡Difference due to selection of study groups.
TABLE 2. Carotid IMT in Subjects With HypoALP and
HyperALP and in Controls (mm)
HypoALP Controls HyperALP
Common carotid IMT 0.870.06 0.650.03‡ 0.680.03†
Carotid bifurcation IMT 1.120.08 0.890.05* 0.880.06†
Internal carotid IMT 0.870.10 0.620.04* 0.670.04
Avg-IMT 0.940.06 0.690.03† 0.710.04†
Max-IMT 1.860.16 1.350.10* 1.380.14*
Data are expressed as meanSEM.
*P0.05; †P0.01, and ‡P0.001 vs HypoALP.
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The measurement of carotid IMT in cases with HypoALP
and HyperALP thus indicates that a low HDL-C level is
associated with significant pre-intrusive atherosclerosis,
whereas a plasma HDL-C level above average values does
not lead to further protection from arterial thickening. To
further prove this concept, we measured the carotid IMT in a
large cohort of hyperlipidemic subjects with widely distrib-
uted plasma HDL-C levels. The characteristics of these
individuals are reported in Table 3. As expected, women had
higher average HDL-C values and lower IMT values at all the
analyzed carotid segments, as well as lower Avg-IMT and
Max-IMT than the men had (Table 3). The entire cohort of
hyperlipidemic subjects was then stratified into quintiles of
HDL-C; significantly greater age-adjusted Avg-IMT and
Max-IMT values were found in subjects belonging to the first
HDL-C quintile (41 mg/dL) than in all the others (Figure
1). No differences in carotid IMT values were instead
detected among subjects belonging to the 2nd to 5th quintiles.
When IMT measurements in men and women were consid-
ered separately, men displayed higher IMT than did women
over the entire HDL-C range (Figure I, please see http://
www.atvb.ahajournals.org). Both in men and women, the
highest Avg-IMT and Max-IMT values were found in those
belonging to the first HDL-C quintile; the impact of a low
HDL-C on IMT was greater in men than in women (Figure I).
A significant inverse linear correlation between carotid
IMT and plasma HDL-C levels was found in the whole cohort
of hyperlipidemic subjects (r-0.11, P0.007 and r-0.12,
P0.003 for Avg-IMT and Max-IMT, respectively). A num-
ber of other parameters correlated significantly with Avg-
IMT and Max-IMT in univariate analysis. Therefore, a
stepwise multiple regression analysis was performed with
Avg-IMT and Max-IMT as the dependent variable, and these
various parameters as independent variables. In both cases,
age and HDL-C were the first and second strongest predictors
of arterial wall thickening, with blood pressure, plasma
glucose, and LDL-C making minor additional contributions
to these associations (Table 4).
In view of the known interaction of plasma HDL-C and
LDL-C levels in determining individual CAD risk, the
association of HDL-C with Avg-IMT and Max-IMT was
further investigated by correlation analysis after stratification
of the hyperlipidemic subjects into tertiles of LDL-C (Table
5). A significant inverse correlation between plasma HDL-C
and Avg-IMT, or Max-IMT was found in each LDL-C tertile;
the slope and the significance of the correlations increased
from the lower to the higher LDL-C tertiles (Table 5),
suggesting an interaction between low HDL-C and high
LDL-C in determining individual carotid arterial thickening.
When the data from the whole cohort were analyzed together,
no significant correlation was found between the individual
HDL-C/LDL-C ratio and either Avg-IMT (r-0.034;
P0.472), or Max-IMT (r0.038; P0.416).
Discussion
Various population and prospective studies have shown
associations between pre-intrusive atherosclerosis, as as-
sessed by measuring carotid arterial wall thickening by
noninvasive ultrasonography, and cardiovascular risk factors,
TABLE 3. Characteristics of Hyperlipidemic Subjects
Hyperlipidemic Subjects
Total Male Female
No. 559 245 314
Sex, F/M 314/245 0/245 314/0
Age, y 53.60.5 51.10.8 55.60.7‡
BMI, kg/m2 23.60.1 24.20.2 23.20.2‡
Total cholesterol,
mg/dL
265.92.4 255.63.9 273.73.1‡
LDL-cholesterol, mg/dL 186.32.4 178.43.8 192.43.1†
HDL-cholesterol, mg/dL 52.40.6 46.70.8 56.90.7‡
Triglycerides, mg/dL 126 (32–850) 138 (34–850) 115 (32–703)‡
Lp(a), mg/dL 22.1 (0.5–171) 19.0 (0.5–150) 23.7 (0.5–171)
Glucose, mg/dL 94.31.0 96.31.7 92.91.2
Systolic BP, mm Hg 133.40.8 133.41.2 133.31.0
Diastolic BP, mm Hg 82.10.4 82.20.7 82.00.6
Hypertension 152 (27.2%) 54.0 (22.0%) 98.0 (31.2%)
Smokers 250 (44.7%) 170.0 (69.4%) 80.0 (25.5%)†
Common Carotid
IMT, mm
0.730.015 0.770.03 0.700.01*
Carotid bifurcation
IMT, mm
0.940.022 1.010.04 0.900.02†
Internal carotid
IMT, mm
0.720.017 0.780.03 0.680.02†
Avg-IMT, mm 0.740.014 0.790.03 0.710.01†
Max-IMT, mm 1.550.042 1.680.08 1.450.05*
Data are expressed as meanSEM, except for triglycerides and Lp(a)
[median (range)] and hypertension and smokers [n (%)].
*P0.05, †P0.01, and ‡P0.001 vs male subjects.
Age-adjusted average (top) and maximal (bottom) carotid IMT in
a cohort of 559 hyperlipidemic subjects stratified into quintiles
of HDL-Cholesterol. Results are expressed as meanSEM. The
HDL-Cholesterol values in the five quintiles were: 41 mg/dL,
41 to 47 mg/dL, 48 to 54 mg/dL, 55 to 64 mg/dL, and 64
mg/dL.
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such as increased age, history of coronary heart disease,
increased blood pressure, history of smoking, insulin resis-
tance, and dyslipidemia.5,7–9,22–27 In some7,8,22–24,27 but not all
these studies,25 an inverse correlation between arterial thick-
ening and HDL-C was found. To the best of our knowledge,
this is the first study examining carotid arterial thickening in
individuals at the two extremities of the HDL-C distribution,
ie, subjects with primary HypoALP or HyperALP, who are
generally considered at high and low CAD risk, respectively.
The results indicate that: (1) The low plasma HDL-C in
subjects with HypoALP is associated with a significant
thickening of the carotid arterial wall; in contrast, the high
HDL-C in HyperALP subjects does not reduce arterial
thickness below that of individuals with average HDL-C. (2)
In a large cohort of hyperlipidemic subjects, a curvilinear
relationship exists between plasma HDL-C and carotid thick-
ening, with the greatest influence of HDL-C on IMT being
from low to average values. (3) HDL-C is a strong indepen-
dent predictor of carotid wall thickening in hyperlipidemic
subjects, and its influence on IMT increases with increasing
plasma LDL-C levels. These results may have important
clinical implications, because a carotid IMT of the magnitude
found in the examined subjects with low HDL-C is associated
with future stroke, CAD events, and death.10,11
Primary HypoALP includes a variety of HDL deficiency
states with heterogeneous genetic, biochemical, and clinical
features. Many HypoALP subjects carry mutations in differ-
ent genes, including those coding for the ABCA1 transporter,
apolipoproteins A-I and A-II, LCAT, or LPL.3 Whereas
homozygous and heterozygous carriers of ABCA1 or LPL
mutations are generally at high CAD risk, no such clear
association between low HDL and CAD risk is found in
carriers of apolipoprotein or LCAT mutations.13 The same
uncertainty exists for individuals at the high extremity of the
HDL-C distribution; whereas a high HDL-C level is generally
considered a protective factor against CAD development,1,15
some individuals, in whom the high HDL-C reflects the
accumulation of dysfunctional HDL,28 are indeed exposed to
a high CAD risk.16 In view of the present difficulties in
defining the CAD risk in individuals with low or high HDL-C
levels, we used IMT as a surrogate marker for the presence of
CAD.29
A major finding in the present study is the remarkable
difference in carotid IMT among the three groups of inves-
tigated subjects. HypoALP individuals have markedly in-
creased IMT, whereas HyperALP and control subjects have
remarkably similar IMT. A larger heterogeneity in arterial
thickening, as depicted by the greater SEM values for either
single-segment or average IMT measurements, was observed
among HypoALP subjects than in subjects with average or
high HDL-C values (Table 2). A systematic genetic charac-
terization of HypoALP individuals recruited for the present
study is currently under way to investigate the impact of
mutations in specific genes on arterial conditions in the
TABLE 4. Stepwise Multiple Regression Analysis of Avg-IMT and Max-IMT to
Risk Factors in Hyperlipidemic Subjects
Dependent Variable Independent Variable  SE() F P
Avg-IMT Age 0.01076 0.00123 76.98 0.0001
HDL-cholesterol 0.00451 0.00121 14.57 0.0002
Systolic BP 0.00400 0.00105 13.98 0.0002
LDL-cholesterol 0.00075 0.00024 9.29 0.0024
Diastolic BP 0.00483 0.00178 7.33 0.0070
Glucose 0.00219 0.00099 4.87 0.0278
Max-IMT Age 0.02703 0.00333 66.04 0.0001
HDL-cholesterol 0.01064 0.00334 10.15 0.0015
Systolic BP 0.00672 0.00223 9.06 0.0027
Glucose 0.00670 0.00274 5.99 0.0147
Variables not entered in the Avg-IMT model: total cholesterol, triglycerides, Lp(a), and BMI.
Variables not entered in the Max-IMT model: total cholesterol, LDL-cholesterol, triglycerides, Lp(a),
diastolic BP, and BMI.
TABLE 5. Correlation of Age-Adjusted Avg-IMT and Max-IMT to HDL-Cholesterol
in Hyperlipidemic Subjects Stratified According to Plasma LDL-Cholesterol Levels
1st LDL-C Tertile
(162 mg/dL)
2nd LDL-C Tertile
(162–196 mg/dL)
3rd LDL-C Tertile
(196 mg/dL)
Age-adjusted Avg-IMT
equation y0.0032x0.9064 y0.0033x0.8761 y0.0057x1.0646
r 0.17 0.20 0.29
p 0.01 0.002 0.00001
Age-adjusted Max-IMT
equation y0.0087x2.0457 y0.0115x2.0708 y0.0163x2.485
r 0.11 0.18 0.28
p 0.09 0.005 0.00001
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affected individuals. It is noteworthy that the carriers of the
apolipoprotein A-IMilano mutant, who are at low CAD risk
despite plasma HDL-C levels lower than those of the present
HypoALP subjects, have IMT values remarkably similar to
those of present controls, and therefore lower than HypoALP
subjects.30
Low HDL levels are often found in the presence of other
risk factors, such as high triglycerides, elevated concentra-
tions of atherogenic triglyceride-rich lipoprotein remnants,
some degree of insulin resistance, and obesity. All these
alterations have been associated with increased IMT.8,23,26
The HypoALP subjects examined in the present study had
higher average triglyceride, glucose, and BMI values than
control and HyperALP subjects. The increased thickening of
carotid arteries in HypoALP subjects compared with controls
remained significant after adjustment for BMI, plasma tri-
glyceride, and glucose levels. Moreover, in the large series of
hyperlipidemic subjects, a low HDL-C was the second
strongest predictor (after age) of increased IMT, whereas no
association was found between IMT and plasma triglycerides.
All together, these data indicate that a low HDL-C per se is a
predictor of pre-intrusive atherosclerosis, independent of
plasma triglycerides.
In the hyperlipidemic subjects, both low HDL-C and high
LDL-C were independent predictors of carotid thickening, ie,
consistent with the independent effect of these two lipopro-
teins on CAD risk.1 More interesting, the influence of low
HDL-C on both Avg-IMT and Max-IMT increased with
increasing plasma LDL-C levels. Previous reports have in-
deed shown that HDL-C correlates negatively with carotid
atherosclerosis in patients with severe hypercholesterol-
emia,24 but not in those with moderate elevations of LDL-
cholesterol.25 It could be argued that a low HDL-C increases
its pro-atherogenic potential in the presence of a high global
risk, as exemplified here by a moderate elevation of LDL-C,
and that the present results may not be generalized to healthy
populations. However, a low HDL-C was found to be an
independent predictor of increased IMT in different popula-
tions,7,22 including those at very low CAD risk.27
HDLs are able to remove cholesterol from a variety of
cells, including those present in the arterial wall.31 Cell
cholesterol removal is the first step of reverse cholesterol
transport, the process by which HDLs transport excess
cholesterol from peripheral tissues, including the arterial
wall, to the liver for excretion.3 Studies in humans and in
transgenic mice expressing human HDL apolipoproteins have
shown that the individual cholesterol efflux capacity is
inversely correlated with plasma HDL level.31 Therefore, a
low plasma HDL concentration would result in defective
cholesterol removal from the arterial wall and faster plaque
growth that would be seen by using ultrasound as a preva-
lence of echolucent plaques,32 and a greater carotid IMT, as
shown in the present study. HDL can also downregulate the
cytokine-induced expression of cell adhesion molecules
(CAMs) in cultured endothelial cells.4 CAMs mediate the
adhesion and transmigration of leukocytes, and thus play a
critical role in early atherogenesis. Indeed, the level of
circulating CAMs is positively associated with the extent of
ultrasound-assessed preclinical atherosclerosis.33 Therefore, a
systemic inflammatory state in subjects with low HDL might
also contribute to the increased carotid IMT observed in the
present study.
HyperALP has been generally associated with longevity
and increased protection against the development of athero-
sclerotic vascular disease.15 This association has been re-
cently questioned by the observation that an increased plasma
HDL-C level in subjects carrying mutations in the CETP gene
is an independent risk factor for CAD.16 In the present study,
HyperALP subjects displayed Avg-IMT and Max-IMT val-
ues identical to those of age- and sex-matched subjects with
average plasma HDL-C levels. Consistent with this finding,
hyperlipidemic subjects in the highest HDL-C quintile
showed the same degree of carotid intimal thickening of
subjects with average plasma HDL-C values. Some of the
HyperALP or high-HDL subjects may carry mutations in the
CETP genes, leading to defective cholesterol removal from
peripheral cells,28 and increased intimal thickening. More
likely, an average plasma HDL-C concentration is sufficient
to prevent excessive arterial lipid deposition and thickening.
The present findings may have important clinical implica-
tions for current strategies aimed at preventing cardiovascular
disease through a raising of plasma HDL-C levels.34 The
observation of a curvilinear relationship between HDL-C and
arterial thickening, if confirmed in prospective studies, sug-
gests that there is no need to increase plasma HDL-C above
average values and that attention should be focused on
individuals with low HDL-C levels and high global risk who
are likely to have the greatest benefit from an HDL-elevating
therapy.
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